GB

Girish Bathina

Active Director Director DIN 09210971
DIN 09210971 First appointment Jun 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Girish Bathina

Data last updated:

Girish Bathina is a Director at Perlin Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals.

DIN 09210971
Primary Designation Director
Industry Chemicals
First Appointment 28 Jun 2021
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Jun 20212019Active

Board colleagues of Girish Bathina

Directorship timeline

Open interactive timeline →
Perlin Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Girish Bathina

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Girish Bathina

Girish Bathina currently holds 1 directorship: Perlin Pharmaceuticals Private Limited (Director, since 28 Jun 2021).

Girish Bathina was first appointed on 28 Jun 2021 as Director at Perlin Pharmaceuticals Private Limited.

The current boards of Girish Bathina's companies include Lalitha Akondi (Perlin Pharmaceuticals Private Limited), Satya Srinivas Tangella (Perlin Pharmaceuticals Private Limited), Suryaprabha Anasuri (Perlin Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available